Pharma Executive The review of Russian Biotech industry and most important players in the beginning of 2014.
PWC PwC vision of Pharma 2020 pillars. The description of 3 fundamental challenges: rising customer expectation, poor scientific productivity, cultural sclerosis.
KPMG in association with Venture Valuation This analysis is aimed at helping entrepreneurs to choose the best possible spot to set up Biotechnology business in EU. The report compares leading EU Life Science Clusters: France, Germany, Ireland, the Netherlands...
BIO - Biotechnology Industry Organization This report by BIO is a digest of noteworthy public policy strategies and programs to assist policy leaders and their bioscience industry partners in identifying new and innovative measures to create, nurture, and...
Venture Valuation The analysis of life sciences indusrty in South Korea in 2015. The report discusses key activities, ownership type, financing raised, therapeutic products in the Pipeline of Korea Biotech industry players.
The analysis of life sciences indusrty in South Korea in 2014. The report discusses key activities, ownership type, financing raised, therapeutic products in the Pipeline of Korea Biotech industry players.
A list of classification standars across various healthcare industries in form of a presentation.